Perioperative use of dexmedetomidine in older patients undergoing spinal surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17013065

Enrollment

Unknown

Registered

2017-10-21

Start date

2018-06-30

Completion date

Unknown

Last updated

2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal surgery

Interventions

D:Dexmedetomidine

C:normal saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) ASA II~III; (2) patients older than 65 years; (3) good communication; (4) sign informed consent

Exclusion criteria

Exclusion criteria: Patients were excluded if they met any of the following criteria: preoperative history of schizophrenia, epilepsy, Parkinsonism, or myasthenia gravis; inability to communicate in the preoperative period (coma, profound dementia, or language barrier); brain injury or neurosurgery; known preoperative left ventricular ejection fraction less than 30%, sick sinus syndrome, severe sinus bradycardia (3hs; blood loss>400ml;segment more than 3; secondary surgery; participate in other clinical trials in 3 months.

Design outcomes

Primary

Measure	Time frame
efficacy;safety;	—

Countries

China

Contacts

Public ContactHongbin Yuan

Department of Anesthesiology, Changzheng Hospital

jfjczyy@163.com+86 13795229316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026